BioCentury
ARTICLE | Top Story

Centocor returns antibody to Crucell

December 24, 2002 8:00 AM UTC

Centocor (Malvern, Penn.) returned to Crucell (Euronext:CRXL; CRXL) all rights to the CD46 target and anti-CD46 antibody, which it had licensed in 2001. Centocor, a Johnson & Johnson (JNJ) subsidiary,...